ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT00832208
Previous Study | Return to List | Next Study

Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00832208
Recruitment Status : Terminated
First Posted : January 30, 2009
Last Update Posted : January 21, 2016
Sponsor:
Collaborator:
Addis Ababa University
Information provided by (Responsible Party):
Drugs for Neglected Diseases